Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
21
pubmed:dateCreated
1990-12-7
pubmed:abstractText
Eukaryotic protein synthesis initiation factor 4E (eIF-4E) is a 25-kDa polypeptide that binds to the 7-methylguanosine-containing cap of mRNA and participates in the transfer of mRNA to the 40S ribosomal subunit, a step that is rate-limiting for protein synthesis under most cellular conditions. eIF-4E is the least abundant of the initiation factors, is present at approximately 10% of molar concentration of mRNA, and thus may serve as a site of regulation for the recruitment of mRNA into polysomes. Previous studies have indicated that phosphorylation of eIF-4E at Ser-53 is correlated with an increased rate of protein synthesis in a variety of systems in vivo and is required for eIF-4E to become bound to the 48S initiation complex. In this study we show that overexpression of eIF-4E in HeLa cells using an episomally replicating, BK virus-based vector leads to an unusual phenotype: cells grow rapidly, forming densely packed, multilayered foci. They progressively form syncytia, some containing as many as six nuclei, and ultimately lyse 1 month after transfection. Some of these properties are reminiscent of oncogenically transformed cells. Cells transfected with the identical vector expressing a variant of eIF-4E, which contains alanine at position 53 and thus cannot be phosphorylated at the major in vivo site, grow normally. Estimations using the Ala-53 variant or a bacterial chloramphenicol acetyltransferase reporter gene in the same vector indicate that the degree of eIF-4E overexpression is 3- to 9-fold more than the endogenous level. These results suggest that eIF-4E may play a key role in cell cycle progression.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/2122455-2105935, http://linkedlifedata.com/resource/pubmed/commentcorrection/2122455-2191953, http://linkedlifedata.com/resource/pubmed/commentcorrection/2122455-229976, http://linkedlifedata.com/resource/pubmed/commentcorrection/2122455-2303467, http://linkedlifedata.com/resource/pubmed/commentcorrection/2122455-2348862, http://linkedlifedata.com/resource/pubmed/commentcorrection/2122455-2564315, http://linkedlifedata.com/resource/pubmed/commentcorrection/2122455-2910847, http://linkedlifedata.com/resource/pubmed/commentcorrection/2122455-2914915, http://linkedlifedata.com/resource/pubmed/commentcorrection/2122455-3010318, http://linkedlifedata.com/resource/pubmed/commentcorrection/2122455-3038908, http://linkedlifedata.com/resource/pubmed/commentcorrection/2122455-3062383, http://linkedlifedata.com/resource/pubmed/commentcorrection/2122455-3065823, http://linkedlifedata.com/resource/pubmed/commentcorrection/2122455-3112145, http://linkedlifedata.com/resource/pubmed/commentcorrection/2122455-3238751, http://linkedlifedata.com/resource/pubmed/commentcorrection/2122455-3469651, http://linkedlifedata.com/resource/pubmed/commentcorrection/2122455-3530248, http://linkedlifedata.com/resource/pubmed/commentcorrection/2122455-3549281, http://linkedlifedata.com/resource/pubmed/commentcorrection/2122455-3793730, http://linkedlifedata.com/resource/pubmed/commentcorrection/2122455-3856321, http://linkedlifedata.com/resource/pubmed/commentcorrection/2122455-3857582, http://linkedlifedata.com/resource/pubmed/commentcorrection/2122455-3891747, http://linkedlifedata.com/resource/pubmed/commentcorrection/2122455-4524638, http://linkedlifedata.com/resource/pubmed/commentcorrection/2122455-5432063, http://linkedlifedata.com/resource/pubmed/commentcorrection/2122455-6164076, http://linkedlifedata.com/resource/pubmed/commentcorrection/2122455-6286831, http://linkedlifedata.com/resource/pubmed/commentcorrection/2122455-6321212, http://linkedlifedata.com/resource/pubmed/commentcorrection/2122455-6351725, http://linkedlifedata.com/resource/pubmed/commentcorrection/2122455-6696877
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0027-8424
pubmed:author
pubmed:issnType
Print
pubmed:volume
87
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
8212-6
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1990
pubmed:articleTitle
Overexpression of eukaryotic protein synthesis initiation factor 4E in HeLa cells results in aberrant growth and morphology.
pubmed:affiliation
Department of Biochemistry, University of Kentucky College of Medicine, Lexington 40536.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S.